Overview

Pneumonia Vaccine Market is forecasted to value over USD 9.7 billion by 2027 end and register a CAGR of 4.9% from the forecast period 2020-2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of this market along with the growth opportunities present across this business vertical.

Major players included in the Pneumonia Vaccine Market are :    

• GlaxoSmithKline
• Pfizer
• Merck
• LG Chem Ltd.
• Panacea Biotec Limited
• Pnuvax Incorporated
• Serum Institute of India Pvt. Ltd.
• SK Bioscience
• Walvax Biotechnology Co., Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Pneumonia Vaccine Market Segmentation:

By Vaccine Type

• Pneumococcal Conjugate Vaccine
• Pneumococcal Polysaccharide Vaccine

By Product Type

• Prevnar 13
• Synflorix
• Pneumovax 23

By Sector

• Public
• Private

By Distribution Channel

• Distribution Partner Companies
• Non-governmental Organizations (NGO)
• Government Authorities

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the market by vaccine type, by product type, by sector, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Pneumonia Vaccine Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Pneumonia Vaccine Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Pneumonia Vaccine Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Pneumonia Vaccine Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Global Pneumonia Vaccine Market, By Vaccine Type Historical Analysis and Forecast 2020-2027 (USD Million)
        7.1. Pneumococcal Conjugate Vaccine
        7.2. Pneumococcal Polysaccharide Vaccine
8. Global Pneumonia Vaccine Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
        8.1. Prevnar 13
        8.2. Synflorix
        8.3. Pneumovax 23
9. Global Pneumonia Vaccine Market, By Sector Historical Analysis and Forecast 2020-2027 (USD Million)
        9.1. Public
        9.2. Private
10. Global Pneumonia Vaccine Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million)
        10.1. Distribution Partner Companies
        10.2. Non-governmental Organizations (NGO)
        10.3. Government Authorities
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2020-2027 
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
        16.1. GlaxoSmithKline
                   16.1.1. Company Overview
                   16.1.2. Product Portfolio
                   16.1.3. SWOT Analysis
                   16.1.4. Financial Overview
                   16.1.5. Strategic Overview
        16.2. Pfizer
                   16.2.1. Company Overview
                   16.2.2. Product Portfolio
                   16.2.3. SWOT Analysis
                   16.2.4. Financial Overview
                   16.2.5. Strategic Overview
        16.3. Merck
                   16.3.1. Company Overview
                   16.3.2. Product Portfolio
                   16.3.3. SWOT Analysis
                   16.3.4. Financial Overview
                   16.3.5. Strategic Overview
        16.4. LG Chem Ltd.
                   16.4.1. Company Overview
                   16.4.2. Product Portfolio
                   16.4.3. SWOT Analysis
                   16.4.4. Financial Overview
                   16.4.5. Strategic Overview
        16.5 Panacea Biotec Limited
                   16.5.1. Company Overview
                   16.5.2. Product Portfolio
                   16.5.3. SWOT Analysis
                   16.5.4. Financial Overview
                   16.5.5. Strategic Overview
        16.6 Pnuvax Incorporated
                   16.6.1. Company Overview
                   16.6.2. Product Portfolio
                   16.6.3. SWOT Analysis
                   16.6.4. Financial Overview
                   16.6.5. Strategic Overview
        16.7. Serum Institute of India Pvt. Ltd.
                   16.7.1. Company Overview
                   16.7.2. Product Portfolio
                   16.7.3. SWOT Analysis
                   16.7.4. Financial Overview
                   16.7.5. Strategic Overview
        16.8. SK Bioscience
                   16.8.1. Company Overview
                   16.8.2. Product Portfolio
                   16.8.3. SWOT Analysis
                   16.8.4. Financial Overview
                   16.8.5. Strategic Overview
        16.9. Walvax Biotechnology Co., Ltd.
                   16.9.1. Company Overview
                   16.9.2. Product Portfolio
                   16.9.3. SWOT Analysis
                   16.9.4. Financial Overview
                   16.9.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures